Evaluated treatment approaches in child and adolescent psychiatry I;Evaluierte behandlungsansätze in der kinder- und jugendpsychiatrie I

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 29, Issue 3, 2001, Pages 189-205

  Baving, L ^a   Schmidt, M H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Controlled study; Evaluation; Evidence based medicine; Pharmacotherapy; Psychotherapy

Indexed keywords

ATTENTION DEFICIT DISORDER; AUTISM; CHILD PSYCHIATRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENURESIS; EVIDENCE BASED MEDICINE; FECES INCONTINENCE; HUMAN; HYPERKINESIA; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIC;

ADOLESCENT; CHILD; COMBINED MODALITY THERAPY; EVALUATION STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034903036     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024//1422-4917.29.3.189     Document Type: Review

References (135)

1. Cognitive training in ADHD children: Less to it than meets the eye
2. Hyperactive children treated with stimulants. Is cognitive training a useful adjunct?
3. Short-term behavioral intervention with delinquent families: Impact on family process and recidivism
4. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
5. Treatment of Tourette syndrome by habit reversal: A waiting-list control group comparison
6. Dry-bed training: Rapid elimination of childhood enuresis
7. Multi-method psycho-educational intervention for preschool children with disruptive behavior: Preliminary results at post-treatment
8. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
9. Das konzept der «Evidence-based Medicine» in der psychiatrie
10. A comparison of dry-bed training and standard urine-alarm conditioning treatment of childhood bed-wetting
11. Multisystemic treatment of serious juvenile offenders: Long-term prevention of criminality and violence
12. Combination therapy for nocturnal enuresis with desmopressin and an alarm device
13. Adverse effects of clornipramine
14. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study
15. Lithium in hospitalized aggressive children with conduct disorder: A double-blind and placebo-controlled study
16. A comparison of haloperidol and behavior therapy and their interaction in autistic children
17. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder
18. Defining empirically supported therapies
19. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience
20. Secretin and autism: A two-part clinical investigation
21. Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design
22. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
23. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
24. A pilot study of nadolol for overt aggression in developmentally delayed individuals
25. Bupropion hydrochloride in attention deficit disorder with hyperactivity
26. Simple electromyographic biofeedback treatment for chronic pediatric constipation/encopresis: Preliminary report
27. Contribution of behavior therapy and biofeedback to laxative therapy in the treatment of pediatric encopresis
28. Additive benefits of laxative, toilet training, and biofeedback therapies in the treatment of pediatric encopresis
29. Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study
30. A comparison of conditioning and psychotherapy in the treatment of functional enuresis
31. Amisulpride versus bromocriptine in infantile autism: A controlled crossover comparative study of two drugs with opposite effects on dopaminergic function
32. Training parents of hyperactive children in child management: A comparative outcome study
33. Functional communication training to reduce challenging behavior: Maintenance and application in new settings
34. Methylphenidate versus dextroamphetamine in children with attention deficit hyperactivity disorder: A double-blind crossover trial
35. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride
36. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism
37. Naltrexone and communication skills in young children with autism
38. A double-blind pilot study of risperidone in the treatment of conduct disorder
39. Use of risperidone in pervasive developmental disorders: A case series
40. Parent-assisted transfer of children's social skills training: Effect on children with and without attention-deficit hyperactivity disorder
41. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
42. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial
43. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial
44. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder
45. Early Intervention Project: Can its claims be substantiated and its effects replicated?
46. Motor performance in hyperactive children treated with imipramine
47. Cognitive mediators of aggression in adolescent offenders: 2. Intervention
48. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder
49. Case study: Rsperidone treatment of children and adolescents with developmental disorders
50. Use of differential reinforcement of other behavior during dyadic instruction to reduce stereotyped behavior of autistic students
51. Family preservation using multisystemic therapy: An effective alternative to incarcerating serious juvenile offenders
52. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: An open multicentre study
53. Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: An open retrospective clinical report
54. Olanzapine in PDD
55. Improved social and language skills after secretin administration in patients with autistic spectrum disorders
56. Effectiveness of psychological and pharmacological treatments for nocturnal enuresis
57. Prevention of relapse in full-spectrum home training for primary enuresis: A components analysis
58. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial
59. Teaching children with autism to initiate and sustain cooperative play
60. Clonidine treatment of hyperactive and impulsive children with autistic disorder
61. Introduction
62. Treatment of children with autism: A randomized controlled trial to evaluate a caregiver-based intervention program in community day-care centers
63. Carbamazepine in hospitalized aggressive conduct disorder children: An open pilot study
64. A controlled trial of desmopressin and behavioral therapy for nocturnal enuresis
65. Olanzapine in Tourette's disorder
66. Cognitive problem-solving skills training and parent management training in the treatment of antisocial behavior in children
67. Impact of family systems intervention on recidivism and sibling delinquency: A model of primary prevention and program evaluation
68. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder
69. Increasing speech intelligibility in children with autism
70. Producing speech use in nonverbal autistic children by reinforcing attempts
71. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings
72. Naltrexone in young autistic children: A double-blind, placebo-controlled crossover study
73. Naltrexone in young autistic children: Replication study and learning measures
74. Amitriptyline in treatment of hyperkinetic children. A double-blind study
75. Programming participation in family activities for children with autism: Parents' use of photographic activity schedules
76. Clonidine treatment of Gilles de la Tourette's syndrome
77. Effectiveness of a social relations intervention program for aggressive and nonaggressive, rejected children
78. Modulation of abnormal defecation dynamics by biofeedback treatment in chronically constipated children with enopresis
79. Biofeedback treatment for chronic constipation and encopresis in childhood: Long-term outcome
80. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
81. Behavioral treatment and normal educational and intellectual functioning in young autistic children
82. Olanzapine for autistic disorder with hyperactivity
83. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder
84. Pemoline hepatotoxicity in children
85. Teaching children with autism to use photographic activity schedules: Maintenance and generalization of complex response chains
86. Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study
87. Long-term outcome for children with autism who received early intensive behavioral treatment
88. Promoting reciprocal interactions via peer incidental teaching
89. Conversational skills for autistic adolescents: Teaching assertiveness in naturalistic game settings
90. Primary nocturnal enuresis: A comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems
91. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyeractivity disorder
92. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
93. Randomised controlled trial of biofeedback training in persistent encopresis with anismus
94. Sertraline in PDD
95. Effectiveness of a home program intervention for young children with autism
96. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline
97. Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures
98. Fluoxetine in children with autism
99. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
100. Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up
101. Social skills training with parent generalization: Treatment effects for children with attention deficit disorder
102. Outcome of parent-mediated treatment of preschoolers with attention deficit disorder with hyperactivity
103. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder
104. Use of methylphenidate in the treatment of children with autistic disorder
105. Childhood enuresis. II. Psychopathology, tricyclic concentration in plasma, and antienuretic effects
106. Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison
107. Clinical effect of buspirone in autistic children
108. The efficacy of a response cost-based treatment package for managing aggressive behavior in preschoolers
109. Therapie der tic-störungen
110. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome
111. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
112. A pilot study of clomipramine in young autistic children
113. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder
114. Relation of behavioral treatment to «normal functioning»: Comment on Lovaas
115. Behavioral training for siblings of autistic children
116. Efficacy of parent-child interaction therapy: Interim report of a randomized trial with short-term maintenance
117. Olanzapine in Tourette's disorder
118. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine
119. Oral desmopressin: A randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis
120. Nocturnal enuresis: A placebo controlled trial of two antidepressant drugs
121. Randomized trial of intensive early intervention for children with pervasive developmental disorder
122. Effects of methylphenidate and behavioral contingencies on sustained attention in attention-deficit hyperactivity disorder: A test of the reward dysfunction hypothesis
123. Phamacotherapy of attention-deficit hyperactivity disorder across the life cycle
124. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorder
125. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder
126. Biofeedback training in treatment of childhood constipation: A randomised controlled study
127. Arousal training for children suffering from nocturnal enuresis: A 21/2 year follow-up
128. Enhancing the effectiveness of self-administered videotape parent training for families with conduct-problem children
129. Treating children with early-onset conduct problems: A comparison of child and parent training interventions
130. The long-term effectiveness and clinical significance of three cost-effective training programs for families with conduct-problem children
131. Nortriptyline in the treatment of ADHD: A chart review of 58 cases
132. Comparison of desmopressin and enuresis alarm for nocturnal enuresis
133. The effects of chronic naltrexone treatment in young autistic children: A double-blind placebo-controlled crossover study
134. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children
135. Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation